NDC 0703-4502-01 - Metoclopramide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0703-4502
- Requested NDC
- 0703-4502-01
- Package NDCs from labels
- 0703-4502-01, 0703-4502-04, 0703-4502-91, 0703-4502-93, 0703-4502-81, 0703-4502-84
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-09-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metoclopramide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-09-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Metoclopramide Injection, USP Rx only | Teva Parenteral Medicines, Inc. | 2026-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Metoclopramide Injection, USP Rx only | Teva Parenteral Medicines, Inc. | 2026-04-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Metoclopramide - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2020-01-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Metoclopramide Injection USP 4502 Rx only | Teva Parenteral Medicines, Inc. | 2015-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0703-4502-01 | Metoclopramide | 2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 2 | 14 | |
| 0703-4502-04 | Metoclopramide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 14 | |
| 0703-4502-91 | Metoclopramide | 2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 2 | 8 | |
| 0703-4502-93 | Metoclopramide | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0703-4502 | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 13 | Current NDC, Legacy NDC, 2 package rows | 20230628_cccf04bd-7463-40b8-a41f-cb1093c358d7.zip |
| 0703-4502 | METOCLOPRAMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 | Current NDC, Legacy NDC, 2 package rows | 20240906_5645a752-8868-4b51-8b59-48bb4276d763.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0703-4502-01 | ML - Milliliter | 0703-4502 | 3c2e19db-3873-43d2-9b74-efb5910a9860 | 1 | 2014-02-04 |
| 0703-4502-04 | ML - Milliliter | 0703-4502 | 970d311d-0e29-4d91-9b8a-561465ea9a7a | 1 | 2014-01-04 |
| 0703-4502-81 | ML - Milliliter | 0703-4502 | d8a195ab-53f6-411d-a01e-45b69b4e4f51 | 1 | 2015-09-10 |
| 0703-4502-84 | ML - Milliliter | 0703-4502 | b74cc0a4-bfb8-499f-90fb-225c8939f713 | 1 | 2015-09-10 |
| 0703-4502-91 | ML - Milliliter | 0703-4502 | c422a339-78a6-4e65-9e5c-d13779f4857a | 1 | 2015-03-03 |
| 0703-4502-93 | ML - Milliliter | 0703-4502 | 6e09e861-5b9d-4052-a6bd-5b708539b004 | 1 | 2024-10-04 |
| 0703-4502-94 | ML - Milliliter | 0703-4502 | fdf9c277-d402-40d7-a220-a842ac3bfbad | 1 | 2015-03-03 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metoclopramide | METOCLOPRAMIDE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 50a3cf38-66dc-4fa5-8a45-adf959c987ab | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | 311670 W1792A2RVD |
| Sodium Chloride | SODIUM CHLORIDE | Sportpharm LLC | a2c111f6-74d5-4a5d-82ac-d0f237488cb8 | 2026-04-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Method Pharmaceuticals, LLC | 4b08859e-65bd-8255-e063-6394a90af614 | 2026-04-23 | Warnings | 451W47IQ8X |
| Metoclopramide | METOCLOPRAMIDE | Teva Parenteral Medicines, Inc. | cccf04bd-7463-40b8-a41f-cb1093c358d7 | 2026-04-22 | Boxed warning, Warnings, Adverse reactions | ANDA073135 0703-4502-01 0703-4502-04 0703-4502 00703450201 311670 e4deb814-efe2-4ed2-84e6-fc9cde89d9e5 cccf04bd-7463-40b8-a41f-cb1093c358d7 W1792A2RVD |
| Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical, Inc. | a926f913-18fa-4a3e-bfd6-210e1e427960 | 2026-04-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Cardioforce II | ABROTANUM, BOLDO, CIMICIFUGA RACEMOSA, KALI PHOSPHORICUM, TARAXACUM OFFICINALE, CONVALLARIA MAJALIS, MAGNESIA SULPHURICA, OLEANDER, NATRUM MURIATICUM, BELLIS PERENNIS | BioActive Nutritional, Inc. | 733bbb26-7698-4a1b-9dc8-7e3490ffc92b | 2026-04-17 | Warnings | 451W47IQ8X |
| Thyroid HP | BARYTA CARBONICA, CALCAREA CARBONICA, FUCUS VESICULOSUS, IODIUM, NATRUM MURIATICUM, PULSATILLA, SPONGIA TOSTA, THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 3795820a-cf2a-4094-9a02-70e3757b7510 | 2026-04-17 | Warnings | 451W47IQ8X |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Metoclopramide | METOCLOPRAMIDE | Teva Parenteral Medicines, Inc. | 5645a752-8868-4b51-8b59-48bb4276d763 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | ANDA073135 0703-4502-93 0703-4502-91 0703-4502 311670 f69b0326-ca76-4a50-b5ed-1884043326e1 5645a752-8868-4b51-8b59-48bb4276d763 W1792A2RVD |
| Anxiety Relief | ACONITUM NAPELLUS, ARGENTUM NITRICUM, ARSENICUM ALBUM, AURUM METALLICUM, GELSEMIUM SEMPERVIRENS, HYOSCYAMUS NIGER, IGNATIA AMARA, KALI CARBONICUM, MOSCHUS, NATRUM MURIATICUM, PIPER METHYSTICUM | NaturalCare | 9f982e89-655c-49be-85d8-4099a02ed021 | 2026-04-15 | Warnings | 451W47IQ8X |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 451W47IQ8X |
| METOCLOPRAMIDE | METOCLOPRAMIDE | HF Acquisition Co LLC, DBA HealthFirst | 4046830f-4b87-5e6e-e063-6394a90aeeb8 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 311670 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Hospira, Inc. | 373ba08b-33ad-49fc-28a7-928e89a65314 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 311670 W1792A2RVD |
| SODIUM CHLORIDE 1 GRAM | SODIUM CHLORIDE | Gendose Pharmaceuticals, LLC | ce988ae5-61c6-4324-90e1-a94c8a54d0d0 | 2026-04-13 | Warnings | 451W47IQ8X |
| Quantum Resonance | ALCOHOLUS, ALUMINA SILICATA, ANACARDIUM ORIENTALE, AQUA MARINA, BAPTISIA TINCTORIA, CANDIDA ALBICANS, COLLAGEN, DNA, LAVANDULA OFFICINALIS, MEDULLA OSSIS SUIS, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NUX MOSCHATA, PHOSPHORUS, QUARTZ, SILICEA, TELA ARANEA, VALERIANA OFFICINALIS, VISCUM ALBUM | Deseret Biologicals, Inc. | f94a10bd-1c40-42c7-b458-b58070614549 | 2026-04-10 | Warnings | 451W47IQ8X |
| Quantum Resonance | ALCOHOLUS, ALUMINA SILICATA, ANACARDIUM ORIENTALE, AQUA MARINA, BAPTISIA TINCTORIA, CANDIDA ALBICANS, COLLAGEN, DNA, LAVANDULA OFFICINALIS, MEDULLA OSSIS SUIS, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NUX MOSCHATA, PHOSPHORUS, QUARTZ, SILICEA, TELA ARANEA, VALERIANA OFFICINALIS, VISCUM ALBUM | Deseret Biologicals, Inc. | 1467111a-bef6-473d-b7f2-3309a9bb72ce | 2026-04-10 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.